285 related articles for article (PubMed ID: 15523918)
41. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
42. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
43. Scrapie prions: a three-dimensional model of an infectious fragment.
Huang Z; Prusiner SB; Cohen FE
Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
[TBL] [Abstract][Full Text] [Related]
44. Metabolic aspects of prion diseases: an overview.
Vranac T; Bresjanac M
Curr Drug Targets; 2010 Oct; 11(10):1207-17. PubMed ID: 20840065
[TBL] [Abstract][Full Text] [Related]
45. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
46. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.
Telling GC; Scott M; Mastrianni J; Gabizon R; Torchia M; Cohen FE; DeArmond SJ; Prusiner SB
Cell; 1995 Oct; 83(1):79-90. PubMed ID: 7553876
[TBL] [Abstract][Full Text] [Related]
47. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
48. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
[TBL] [Abstract][Full Text] [Related]
49. The multivesicular body is the major internal site of prion conversion.
Yim YI; Park BC; Yadavalli R; Zhao X; Eisenberg E; Greene LE
J Cell Sci; 2015 Apr; 128(7):1434-43. PubMed ID: 25663703
[TBL] [Abstract][Full Text] [Related]
50. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
[TBL] [Abstract][Full Text] [Related]
51. Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neuritogenesis Defects and Prion Accumulation.
Alleaume-Butaux A; Nicot S; Pietri M; Baudry A; Dakowski C; Tixador P; Ardila-Osorio H; Haeberlé AM; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
PLoS Pathog; 2015 Aug; 11(8):e1005073. PubMed ID: 26241960
[TBL] [Abstract][Full Text] [Related]
52. Prion propagation and molecular chaperones.
Zahn R
Q Rev Biophys; 1999 Nov; 32(4):309-70. PubMed ID: 11194568
[No Abstract] [Full Text] [Related]
53. Prion diseases: from transmission experiments to structural biology--still searching for the cause.
Liberski PP; Brown P
Folia Neuropathol; 2004; 42 Suppl A():15-32. PubMed ID: 15449457
[No Abstract] [Full Text] [Related]
54. Molecular advances in understanding inherited prion diseases.
Brown DR
Mol Neurobiol; 2002 Jun; 25(3):287-302. PubMed ID: 12109876
[TBL] [Abstract][Full Text] [Related]
55. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
[TBL] [Abstract][Full Text] [Related]
56. Protein misfolding and disease: the case of prion disorders.
Hetz C; Soto C
Cell Mol Life Sci; 2003 Jan; 60(1):133-43. PubMed ID: 12613663
[TBL] [Abstract][Full Text] [Related]
57. Prion protein biology.
Prusiner SB; Scott MR; DeArmond SJ; Cohen FE
Cell; 1998 May; 93(3):337-48. PubMed ID: 9590169
[No Abstract] [Full Text] [Related]
58. Prion diseases: Infectivity versus toxicity.
Wickner RB
Nature; 2011 Feb; 470(7335):470-1. PubMed ID: 21350474
[No Abstract] [Full Text] [Related]
59. Chaperone-supervised conversion of prion protein to its protease-resistant form.
DebBurman SK; Raymond GJ; Caughey B; Lindquist S
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
[TBL] [Abstract][Full Text] [Related]
60. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
